LIFE QUALITY OF PATIENTS WITH CERVICAL CANCER AFTER THE IMMUNOTHERAPY

Abstract

Research objective - definition of immunotherapy influence on quality of life in patients with cervical cancer in comparison with traditional antineoplastic therapy. 117 patients with cervical cancer, exposed to antineoplastic therapy by means of questionnaire SF-36 are surveyed. Patients were exposed to the complex therapy including specific and adoptive immunotherapy. Relative improvement of quality of life has been reached in group of immunotherapy application, statistically significant according to a number of SF-36 scales.

Keywords

cervical cancer / immunotherapy / quality of life

References

[1] Stensvold E., Magelssen H., Oskam I.C. Fertility-preserving measures for girls and young women with cancer. Tidsskr. Nor-ske Laegeforen. 2011; 131(15): 1429—32.

[2] Hulvat M.C., Jeruss J.S. Fertility preservation options for young women with breast cancer. Curr Opin. Obstetr. Gynecol. 2011; 23(3): 174—82.

[3] Su H.I. Measuring ovarian function in young cancer survivors. Minerva Endocrinol. 2010; 35(4): 259—70.

[4] Jacobsen P.B., Jim H.S. Consideration of quality of life in cancer survivorship research. Cancer Epidemiol Biomarkers Prev. 2011; 20(10): 2035—41.

[5] Claassens L., van Meerbeeck J., Coens C. et al. Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. J Clin. Oncol. 2011; 29(15): 2104—20.

[6] Chase D.M., Watanabe T., Monk B.J. Assessment and significance of quality of life in women with gynecologic cancer. Future Oncol. 2010;6(8): 1279—87.

[7] Zarour H.M., Ferrone S. Cancer immunotherapy: Progress and challenges in the clinical setting. Eur. J. Immunol. 2011; 41(6): 1510—5.

RIGHTS & PERMISSIONS

Eco-Vector